Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation
Condition(s):Transplantation, Lung RejectionLast Updated:September 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Transplantation, Lung RejectionLast Updated:September 1, 2021Completed
Condition(s):Paroxysmal Nocturnal Hemoglobinuria (PNH) With Signs of Active HemolysisLast Updated:January 3, 2024Completed
Condition(s):Pain, Intractable; Pain CancerLast Updated:November 9, 2021Withdrawn
Condition(s):Wilson DiseaseLast Updated:October 10, 2023Terminated
Condition(s):Depressive Disorder, MajorLast Updated:November 8, 2023Terminated
Condition(s):Diabetes; Diabetic Foot; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1Last Updated:August 25, 2021Terminated
Condition(s):Cochlear ImplantLast Updated:January 20, 2022Withdrawn
Condition(s):Covid-19Last Updated:September 21, 2022Terminated
Condition(s):Recurrent Head and Neck Carcinoma; Locally Advanced Head and Neck CarcinomaLast Updated:January 5, 2024Recruiting
Condition(s):Burns; Skin Burn Requiring Skin GraftLast Updated:October 2, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.